ID22763A - Komposisi penstabil tibolon - Google Patents
Komposisi penstabil tibolonInfo
- Publication number
- ID22763A ID22763A IDW991204A ID991204A ID22763A ID 22763 A ID22763 A ID 22763A ID W991204 A IDW991204 A ID W991204A ID 991204 A ID991204 A ID 991204A ID 22763 A ID22763 A ID 22763A
- Authority
- ID
- Indonesia
- Prior art keywords
- tibolon
- stabilizer composition
- dosage unit
- tibolone
- contained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201180 | 1997-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID22763A true ID22763A (id) | 1999-12-09 |
Family
ID=8228228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW991204A ID22763A (id) | 1997-04-22 | 1998-04-20 | Komposisi penstabil tibolon |
Country Status (26)
Country | Link |
---|---|
US (6) | US6399594B2 (ja) |
EP (1) | EP0975348B1 (ja) |
JP (1) | JPH10316573A (ja) |
KR (1) | KR100580855B1 (ja) |
CN (2) | CN1146424C (ja) |
AR (1) | AR012480A1 (ja) |
AT (1) | ATE281836T1 (ja) |
AU (1) | AU742037B2 (ja) |
BR (1) | BR9809268A (ja) |
CA (1) | CA2288070A1 (ja) |
DE (1) | DE69827484T2 (ja) |
DK (1) | DK0975348T3 (ja) |
ES (1) | ES2232949T3 (ja) |
HK (1) | HK1023508A1 (ja) |
HU (1) | HUP0001780A3 (ja) |
ID (1) | ID22763A (ja) |
IL (1) | IL123984A (ja) |
NO (1) | NO995127L (ja) |
NZ (1) | NZ338028A (ja) |
PL (1) | PL190227B1 (ja) |
PT (1) | PT975348E (ja) |
RU (1) | RU2207133C2 (ja) |
TR (1) | TR199902530T2 (ja) |
TW (1) | TW570798B (ja) |
WO (1) | WO1998047517A1 (ja) |
ZA (1) | ZA983169B (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100378116C (zh) * | 1998-10-16 | 2008-04-02 | 欧加农股份有限公司 | 包含(7α,17α)-17-羟基-7-甲基-19-去甲-17-孕-5(10)-烯-20-炔-3-酮的高纯度组合物 |
US7763276B1 (en) * | 1999-02-26 | 2010-07-27 | Shionogi & Co., Ltd. | Chewable soft capsules having improved administration properties and process for producing the same |
US20040229854A1 (en) * | 2000-11-28 | 2004-11-18 | Pieter Haan De | Immediate release dosage form for HRT |
US20070098784A1 (en) * | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
RU2313355C2 (ru) * | 2001-09-28 | 2007-12-27 | Нутрасьютикс, Инк. | Система ввода для биологического компонента |
GB0125061D0 (en) * | 2001-10-18 | 2001-12-12 | Norton Healthcare Ltd | Pharmaceutical composition |
TW200418525A (en) * | 2002-11-20 | 2004-10-01 | Akzo Nobel Nv | Coated pharmaceutical tablets containing Tibolone |
CN1324041C (zh) * | 2003-04-01 | 2007-07-04 | 上海迪赛诺医药科技开发有限公司 | 替勃龙晶型i的制备方法 |
AU2004234057A1 (en) * | 2003-04-29 | 2004-11-11 | Akzo Nobel N.V. | Antisolvent solidification process |
US20060134191A1 (en) * | 2003-05-23 | 2006-06-22 | Pieter De Haan | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
EP1742615A2 (en) * | 2004-05-05 | 2007-01-17 | Akzo Nobel N.V. | Antisolvent emulsion solidification process |
WO2005117899A1 (en) * | 2004-06-02 | 2005-12-15 | Cipla Limited | Pharmaceutical composition comprising tibolone and process for procuding the same |
WO2005120517A1 (en) * | 2004-06-07 | 2005-12-22 | Strides Arcolab Limited | Stable liquid suspension formulation comprising synthetic steroids and process for producing the same |
CZ300465B6 (cs) * | 2007-07-25 | 2009-05-27 | Zentiva, A. S. | Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu |
CN102085193B (zh) * | 2009-12-08 | 2013-11-06 | 北京以岭生物工程技术有限公司 | 一种替勃龙口腔崩解片及其制备方法 |
CN104345098B (zh) * | 2013-08-05 | 2016-04-13 | 华润紫竹药业有限公司 | 一种测定替勃龙片剂中抗氧剂含量的方法 |
DK3452019T3 (da) | 2016-05-04 | 2021-09-06 | Novalon S A | Anvendelse af sukkeralkoholer i tibolonsammensætninger |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4701450A (en) * | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
CH676470A5 (ja) * | 1988-02-03 | 1991-01-31 | Nestle Sa | |
IE63051B1 (en) * | 1989-03-18 | 1995-03-22 | Akzo Nv | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one |
CA2116829C (en) * | 1993-03-05 | 2004-09-14 | Godefridus Hermanus Johanna Deckers | Use of a pregnane derivative |
ES2185666T3 (es) | 1993-09-03 | 2003-05-01 | Smithkline Beecham Corp | Formulacion estabilizada para comprimidos. |
IL115445A (en) * | 1994-10-17 | 1999-08-17 | Akzo Nobel Nv | Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation |
-
1998
- 1998-04-07 IL IL12398498A patent/IL123984A/en active IP Right Grant
- 1998-04-15 ZA ZA983169A patent/ZA983169B/xx unknown
- 1998-04-20 CN CNB988044579A patent/CN1146424C/zh not_active Expired - Fee Related
- 1998-04-20 NZ NZ338028A patent/NZ338028A/en unknown
- 1998-04-20 DK DK98928214T patent/DK0975348T3/da active
- 1998-04-20 TR TR1999/02530T patent/TR199902530T2/xx unknown
- 1998-04-20 HU HU0001780A patent/HUP0001780A3/hu unknown
- 1998-04-20 PL PL98336658A patent/PL190227B1/pl not_active IP Right Cessation
- 1998-04-20 CN CNA2003101026335A patent/CN1494908A/zh active Pending
- 1998-04-20 BR BR9809268-5A patent/BR9809268A/pt not_active Application Discontinuation
- 1998-04-20 US US09/403,139 patent/US6399594B2/en not_active Expired - Fee Related
- 1998-04-20 EP EP98928214A patent/EP0975348B1/en not_active Expired - Lifetime
- 1998-04-20 WO PCT/EP1998/002361 patent/WO1998047517A1/en not_active Application Discontinuation
- 1998-04-20 PT PT98928214T patent/PT975348E/pt unknown
- 1998-04-20 CA CA002288070A patent/CA2288070A1/en not_active Abandoned
- 1998-04-20 AT AT98928214T patent/ATE281836T1/de not_active IP Right Cessation
- 1998-04-20 RU RU99121407/14A patent/RU2207133C2/ru not_active IP Right Cessation
- 1998-04-20 ID IDW991204A patent/ID22763A/id unknown
- 1998-04-20 DE DE69827484T patent/DE69827484T2/de not_active Expired - Fee Related
- 1998-04-20 AU AU80146/98A patent/AU742037B2/en not_active Ceased
- 1998-04-20 ES ES98928214T patent/ES2232949T3/es not_active Expired - Lifetime
- 1998-04-20 KR KR1019997009726A patent/KR100580855B1/ko not_active IP Right Cessation
- 1998-04-21 AR ARP980101819A patent/AR012480A1/es not_active Application Discontinuation
- 1998-04-22 JP JP10112312A patent/JPH10316573A/ja active Pending
- 1998-05-11 TW TW087107211A patent/TW570798B/zh not_active IP Right Cessation
-
1999
- 1999-10-21 NO NO995127A patent/NO995127L/no unknown
-
2000
- 2000-05-03 HK HK00102669A patent/HK1023508A1/xx not_active IP Right Cessation
-
2002
- 2002-04-08 US US10/117,899 patent/US6514958B1/en not_active Expired - Fee Related
- 2002-11-25 US US10/303,494 patent/US20030119801A1/en not_active Abandoned
-
2004
- 2004-01-08 US US10/754,733 patent/US20040142031A1/en not_active Abandoned
- 2004-01-08 US US10/754,732 patent/US20040142028A1/en not_active Abandoned
- 2004-01-08 US US10/754,685 patent/US20040142030A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID22763A (id) | Komposisi penstabil tibolon | |
SE9700135D0 (sv) | New formulation | |
MY118371A (en) | Tetrahydrolipstatin containing compositions | |
ATE240344T1 (de) | Nor-pregnane zur induzierung hypothalamischer effekte | |
DE69940557D1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
ES8402155A1 (es) | Un metodo para producir formas posologicas unitarias solidas que al administrarse siguen una pauta de liberacion regular y prolongada. | |
EP0693924A4 (en) | METHODS OF ADMINISTRATION -i (IN VIVO) OF BIOLOGICAL SUBSTANCES AND COMPOSITIONS USED IN SUCH METHODS | |
ATE329608T1 (de) | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung | |
BR9810495A (pt) | Composição farmacêutica | |
IE891414L (en) | Pharmaceutical compositions | |
IL101056A (en) | Composition for nasal treatment | |
ATE202931T1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
FI870457A0 (fi) | Farmaceutiska preparatformer foer stabilisering av interferon- . | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
CA2348474A1 (en) | Pharmaceutically active composition and dispensing device | |
BG94934A (bg) | Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество | |
MXPA02006034A (es) | Formas de dosis mucosaloral de apomorfina. | |
GB2258397A (en) | Pharmaceutical compositions containing amethocaine | |
DE69808287D1 (de) | Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid | |
NZ241309A (en) | Heterocyclic amido prostaglandin analogues, preparation and pharmaceutical compositions thereof | |
KR970058720A (ko) | 향균 및 항진균 활성을 갖는 펩타이드 | |
ITRM910038A1 (it) | Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale. | |
ATE130190T1 (de) | Ein dihydropyridinderivat in nanosolform enthaltendes retard-arzneimittel und seine herstellung. | |
GB8902069D0 (en) | Pharmaceutical composition comprising 3-(n-piperidino-azino)methylrifamycin s as active ingredient | |
GB9005316D0 (en) | Pharmaceutical composition comprising 3-(n-piperidinomethyl-azino)methylrifamycin s as active ingredient |